The effects of unipolar and bipolar electrostatic charges on the deposition efficiency of therapeutic aerosols in the physical model of human tracheobronchial (TB) airways have been investigated. Respirable size aerosol particles were generated by a commonly prescribed and commercially available nebulizer and charged by a corona charger and then their size and charge distributions were characterized by an Electronic Single ParticleAerodynamic Relaxation Time analyzer to study the drug aerosol particles' deposition pattern. The experiments were performed with a glass bead tracheobronchial model (GBTBM) (physical model) which was designed and developed based upon widely used and adopted dichotomous lung morphometric data presented in the Ewald R. Weibel model. The model was validated with the respiratory deposition data predicted by the International Commission on Radiological Protection and the United States Pharmacopeia (USP) approved Andersen Cascade Impactor (ACI). Unipolarly and bipolarly charged particles were characterized for two configurations: a) without TB model in place and b) with TB model in place. Findings showed that the deposition of unipolarly charged particles was about 3 times of the bipolarly charged particles. It was also found that bioengineered therapeutic aerosols with good combinations ofaerodynamic size and electrostatic charge are good candidates for the administration of respiratory medicinal drugs.


This article is originally published by Arkansas Academy of Science, in the Journal of the Arkansas Academy of Science, under a Creative Commons license: Attribution-NoDerivatives 4.0 International (CC BY-ND 4.0) (https://creativecommons.org/licenses/by-nd/4.0/).


Arkansas Academy of Science

Date of publication




Persistent identifier


Document Type